HYPERTONIA ÉS NEPHROLOGIA - eLitMed.hu

196 DE CHÂTEL RUDOLF HYPERTONIA ÉS NEPHROLOGIA
IRODALOM
1. Prospective Studies Collaboration: Age-specific relevance of usual BP to vascular mortality: A meta-analysis of individual data for one million
adults in 61 prospective studies. Lancet 2002; 360:1903-1913
2. Vasan RS, Beiser A, Seshadri S, et al: Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham
Heart Study JAMA 2002; 287: 1003-1010
3. Hansson L, Zanchetti A, Carruthers S et al: Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension:
principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755-1762.
4. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive treatment in older persons with isolated systolic hypertension: final
results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 191; 265:3255-3264.
5. MR Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412.
6. Dahlöf , Lindholm LM, Hansson L, et al: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Lancet 1991; 338: 1281-1285.
7. Kostis JB, Wilson AC, Freudenberger RS, et al: Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic
hypertension with and without diabetes. Am J Cardiol 2005; 95: 29-35.
8. Barzilay JI, Davis BR, Cutler JA, et al: Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3
different classes of antihypertensive treatment. Arch inter Med. 2006; 166: 2191-2201.
9. Barna I: A fix kombinációk helye a hipertónia korszerû kezelésében. Háziorv Továbbképz Szle 2004; 9: 426-429.
10. The Task Force for the Managmenet of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of
Cardiology (ESC): 2007 Guidelines for the Management of Hypertension. J Hypertens 2007; 25: 1105-1187.
11. de Châtel R: Exforge: az elsõ Ca-antagonista /ARB kombináció Magyarországon. Háziorv Továbbképz Szle 2008; 13: 124-127.
12. Kiss I (szerk): A hypertoniabetegség kezelésének szakmai irányelvei: A Magyar Hypertonia Társaság állásfoglalása. Hypertonia Nephrologia 2008;
12(SZ): 85-154.
13. Beckett NS, Peters R, Fletcher A, et al: Treatment of hypertension in patients 80 years of age or older. NEJM 2008; 358: 1887-1898.